Skip to main content
    O

    OS Therapies Incorporated (OSTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.74
    +0.06 (+9.30%)

    Market Cap: $31.86M

    Last updated: Nov 17, 2026 at 4:21 PM ET

    OS Therapies Incorporated (OSTX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    OS Therapies (OSTX) has a market cap of $31.86M and an enterprise value of $33.38M. Its share count is up 48.52% from a year earlier.

    Total Valuation

    Enterprise value is 4.77% above the market cap, as debt exceeds cash.

    Market Cap$31.86M
    Enterprise Value$33.38M
    Latest price (Nov 17, 2026)$0.74

    Key Dates

    Last Earnings DateAug 14, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 13.39% in the quarter ended Sep 30, 2026 and grew 56.93% a year over 2 years.

    Shares Outstanding52.30M
    Shares Change (YoY)+48.52%
    Shares Change (QoQ)+13.39%
    Share Count Growth (2Y CAGR)+56.93%

    Price Statistics

    The stock is down 58.67% over 52 weeks and trades 46.76% below its 50-day average.

    Beta (1Y)1.65
    52-Week Change-58.67%
    1-Month Change-41.42%
    3-Month Change-49.04%
    6-Month Change-57.73%
    Total Return (1Y)-58.67%
    Max Drawdown (1Y)-69.61%
    Max Drawdown (3Y)-86.81%
    Sharpe Ratio (1Y)-1.09
    Correlation with SPY (1Y)0.29
    50-Day Average$1.39
    200-Day Average$1.53
    52-Week Range$0.58 to $2.25
    RSI (14 Days)22.6
    Average Volume (20 Days)698.13K

    Price chart

    Financial Position

    Current assets cover 0.08x current liabilities.

    Current Ratio0.08x
    Quick Ratio0.08x

    Returns and Efficiency

    Return on invested capital is 218.01% over the last 12 months.

    Return on Assets (ROA)-539.85%
    Return on Invested Capital (ROIC)218.01%

    Scores

    OSTX has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$124.94K
    Operating Income-$39.77M
    Pretax Income-$43.77M
    Net Income-$43.77M
    EBITDA-$39.41M
    EBIT-$41.44M
    Reported EPS (TTM)-$1.09

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$431.82K
    Total Debt$1.95M
    Net Debt$1.52M
    Net Debt Per Share$0.03
    Working Capital-$21.93M
    Shareholder Equity-$16.97M
    Tangible Book Value-$23.10M
    Total Assets$8.11M
    Total Liabilities$24.01M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$18.48M
    FCF Per Share-$0.40
    Depreciation and Amortization$2.04M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    OSTX does not pay a dividend.

    Buyback Yield-19.22%
    Shareholder Yield-19.22%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About OSTX

    What is OSTX's market cap?

    OS Therapies has a market cap of $31.86M. Its enterprise value, which adds debt and subtracts cash, is $33.38M.

    How many shares of OSTX are outstanding?

    OS Therapies has 52.30M shares outstanding. The count is up 48.52% from a year earlier.

    Does OSTX pay a dividend?

    No. OS Therapies does not pay a dividend.

    How much debt does OSTX have?

    OS Therapies has $1.95M of total debt and $431.82K of cash and equivalents, a net debt position of $1.52M.